Working in prostate cancer care? Follow our new LinkedIn page for clinical updates, guidance, education & CPD, practical tools and patient info. Join a dedicated space for healthcare professionals to stay informed, connected and supported. buff.ly/GeYu30f #ProstateCancer #HealthProfessionals

Sexual dysfunction is a common consequence of prostate cancer treatment, and many patients go unsupported due to a lack of discussion or delays in intervention. Watch Prof. Mike Kirby's video for an overview of the use of PDE5 inhibitors in patients treated for prostate cancer.

Top Tips for Primary Care: Optimising PDE5 inhibitor Use In Prostate Cancer Care – Prostate Cancer UK Education

An expert -led overview for primary care clinicians on the early, proactive use of PDE5 inhibitors in patients treated for prostate cancer.

edu.prostatecanceruk.org

📣 Urologists needed to help reduce overtreatment of prostate cancer Help refine an e-learning resource to support discussions about active surveillance and treatments for localised prostate cancer. 90–120 min online focus group. Get involved ➡️ buff.ly/bhnFb7Z

Prostate Cancer UK grants of £500–£10,000 are available for projects raising awareness of prostate cancer among Black men. ➡️ Please share with eligible charities, CICs or CIOs 🕐️ Applications close on 31 July 2026 ✉️ Email bheinbox@prostatecanceruk.org to find out more

Boost your clinical confidence in #prostatecancer care with free, bite-sized e-learning modules authored by radiotherapy and oncology expert Catherine Holborn. These interactive, evidence-based courses align with current guidelines and count towards your self-accredited #CPD. buff.ly/KaQlTRU

📢 Prostate cancer specialists wanted Help refine an e-learning resource to support clinician–patient discussions and informed decision-making about active surveillance and treatment options for low/intermediate-risk prostate cancer. 90–120 min online focus group + £60. Register: buff.ly/qa3Cocf

🩺 NHS England needs clinical & technical experts to join the evaluation panels for the PET-CT Phase 1 Procurement - shaping 50% of England's provision for the next 10 years. Looking for: - Radiologists / NM Physicians - Referring Consultants - Radiographers / Technologists - MPEs (1/2) 👇

We're here to support anyone affected by prostate cancer - whether they need information about a diagnosis, someone who's had treatment to talk to, or help with side effects. We'll cover our support services in this webinar. 📅 24 June 🕕️ 6pm–7.30pm Signpost to patients: buff.ly/Cqxxr1W

From the 29th June, The Patients Association will be hosting free webinars as part of Patient Partnership Week. This will bring together patients, professionals, policymakers, and researchers to explore what meaningful partnership looks like in practice. More information here ➡️ buff.ly/TLwgPdU

What do the latest UK NSC recommendation on prostate cancer screening and TRANSFORM trial expansion mean for practice? Read our summary for health professionals, access FAQs and share your feedback: buff.ly/U2UnXx3

Please share with patients our free webinar. Our upcoming webinar will help men feel less alone and more supported after a prostate cancer diagnosis, with information about our services available and insight from others with lived experience. 📅 24 June 🕕 6pm–7:30pm Details here: buff.ly/cX658LF

Dr Alan McWilliam @manchester.ac.uk leads a #research team working to make #radiotherapy treatment more precise. Since 2021, we’ve supported his team to develop a way to more quickly identify men with #ProstateCancer who are not responding to treatment. 📙 Read more: buff.ly/fQjCGRM

NICE is recruiting a professional member for the Prostate Cancer: Diagnosis & Management committee. If you’re a health or social care professional with relevant expertise, this is a great chance to influence national guidance and improve patient outcomes. Read more & apply ➡️ buff.ly/qwyLij3

Macmillan and @rc-pharm.bsky.social are seeking healthcare professionals’ views on managing medicines and polypharmacy during cancer care. Your insights will help improve medicines optimisation, patient support and care for people affected by cancer. Take the survey ➡️ buff.ly/yIrGMoV

Professor Val Macaulay @ndsurgicalsci.bsky.social led a research group investigating the role of IGF‑1 in #ProstateCancer. Since 2004, we’ve supported her team to explore whether drugs targeting IGF‑1 could help slow the growth of localised prostate cancer. 📙 Read more: buff.ly/GyaDLdr

Could measuring ctDNA & serum PSA identify men with advanced #ProstateCancer who may benefit from treatment intensification? A team @ucl.ac.uk & the University of Trento, led by Profs Francesca Demichelis & Gert Attard, publish findings in @natcancer.nature.com. Grab a ☕ & read: lnkd.in/eeSkYZVX

Dr Robert Kypta at @imperialcollegeldn.bsky.social leads a team exploring novel treatments for #ProstateCancer. Since 2022, we’ve supported his team to develop a new targeted drug delivery approach, helping protect healthy cells and reduce side effects. Read more 📙: bit.ly/4u2x383

📢 Introducing Dr Shaun Scaramuzza, the first of our 2025 Career Acceleration Fellows! 🔬 Shaun’s research aims to improve early detection and treatment options for men at highest risk. Our 2026 round is still open for applications! You can apply here: buff.ly/3fXLLUz

Dr Susan Heavey at @ucl.ac.uk leads a team focused on making drug development more effective. Since 2018, we’ve supported her team to use patient‑derived explants & spatial transcriptomics to identify the most promising #ProstateCancer treatments. 📙 Read more: bit.ly/2ADGYs9

Could PSA levels measured during & after treatment, together with radiological features, help guide personalised treatment decisions for men with #ProstateCancer? A team led by Prof Gert Attard @ucl.ac.uk share new findings in @thelancetoncol.bsky.social. Grab a ☕️ & read: doi.org/10.1016/S147...

Strengthening the UK #prostatecancer clinical research pipeline.🔬 Our April in person CRSG meeting sparked rich discussion on major research proposals & UK wide collaboration. Huge thanks to our proposal presenters, CRSG and Early Career members. 👏 📙https://bit.ly/4mGKnfK

How have the PACE trials influenced radiotherapy treatment for #ProstateCancer? Profs Nicholas van As & @profemmahall.bsky.social @icr.ac.uk share learnings from a decade of trials, including Prostate Cancer UK-funded PACE-NODES, in @ijrobp.bsky.social. Grab a ☕ & read: doi.org/10.1016/j.ij...

The April edition of Research News is here! Read about: 💙 The TRANFORM screening trial. 📢 Our new LinkedIn channel for prostate cancer researchers. 🔬 Research stories with impact. 🏆 Researcher achievements. 💰 Funding opportunities. Read it here 📰 : buff.ly/k09eMvo

Prostate Cancer UK funded a team led by Prof Noel Clarke at the Movember FASTMAN Centre of Excellence to analyse bone scans from the STAMPEDE trial. They explored whether adding radiotherapy to the prostate could help men whose cancer had spread. 📙 prostatecanceruk.org/research/res...

🥼 Professor Simon Mackay @unistrathclyde.bsky.social leads a team developing new treatments for men with advanced #ProstateCancer. 💊 In 2019, we funded Simon to further develop his first-in-class IKKα inhibitor. 📙 Read more about Simon's innovative #research: prostatecanceruk.org/research/res...

📣 Job Opportunity: Biobank Manager for TRANSFORM Discovery. Play a central role in developing a world-leading high-quality data & tissue resource and help TRANSFORM outcomes for men affected by #ProstateCancer. Full details ⤵️ www.imperial.ac.uk/jobs/search-...

Could hypoxia and angiogenesis gene expression help personalise #ProstateCancer radiotherapy? Funded by our Movember FASTMAN Centre of Excellence, Prof Hoskin and Prof Choudhury @christieinstitute.bsky.social share new findings in Clinical Oncology. Grab a ☕ and read: bit.ly/4sHE25b

Our final Patient Research Partner speech comes from Patrick. Diagnosed with Stage 4 #ProstateCancer in 2020, Patrick is dedicated to raising awareness, visiting many organisations and businesses. A huge thank you to all of our inspirational Patient Research Partners 👏

It’s time for the final session of From Ideas to Innovation 2026 🗣️ The focus is on advanced #ProstateCancer, and we’re delighted to be joined by speakers Professor Gerhardt Attard, Dr Ashwin Sachdeva and Dr Emily Grist.

Kicking off the first session of the afternoon 🎤 Simon and Hayley from our research team are sharing how @prostatecanceruk.bsky.social can support researchers - from making key introductions, to our open access reimbursement scheme, to helping their work reach the audiences that matter.